| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |